Diabetes (Type 1)
Diabetes insipidus

Experimental immunotherapy for type 1 diabetes

30 Aug 2017

An immunotherapy approach for treating type 1 diabetes has been found to be safe for the first time, and seems to stop the condition from getting worse. Immunotherapies aim to modulate a person’s...

Telomeres: What causes biological aging?

2 Aug 2017 • 1 comment

If you are wondering how your cells age, look no further than the ends of your chromosomes. Special structures called telomeres keep a close eye on the damage that accumulates in our cells and signal...

All English GPs to have Wi-Fi by end of year

13 Jul 2017

NHS Digital has reiterated its intention to provide free Wi-Fi to all English GP practices by the end of the year, promising that patients will be able to access the internet free of charge in...

Bladder cancer
Brain tumour
Breast cancer
Cancer
Cancer of the pleura
Cancer of the vulva
Cervical cancer
Endocrine cancer
Endometrial cancer
Esophageal cancer
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumour
Larynx cancer
Leiomyosarcoma
Liver cancer
Neuroendocrine liver cancer
Neuroendocrine tumour
Ovarian cancer
Pancreatic cancer
Prostate cancer
Renal cancer
Testicular cancer
Thymus cancer
Thyroid cancer
xyz_Colon cancer

Personalised vaccines to treat skin cancer show promise in small studies

13 Jul 2017 • 1 comment

Personalised vaccines have been used to successfully treat melanoma (skin cancer) patients in two small studies. Researchers used unique differences in each patient’s cancer to design vaccines to...

Bladder cancer
Brain tumour
Breast cancer
Cancer
Cancer of the pleura
Cancer of the vulva
Cervical cancer
Endocrine cancer
Endometrial cancer
Esophageal cancer
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumour
Larynx cancer
Leiomyosarcoma
Liver cancer
Neuroendocrine liver cancer
Neuroendocrine tumour
Ovarian cancer
Pancreatic cancer
Prostate cancer
Renal cancer
Testicular cancer
Thymus cancer
Thyroid cancer
xyz_Colon cancer

From bench to bedside in two years: a new drug for bowel cancer patients starts clinical trials across the UK

12 Jul 2017

Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the CRUK/MRC Oxford Institute...

Arthritis
Rheumatoid arthritis

NRAS: one in three RA patients rejecting meds because of cost

7 Jul 2017

One in three people with rheumatoid arthritis in England are not taking their medicine as prescribed because of cost, according to The National Rheumatoid Arthritis Society (NRAS).Thirty-one percent...

England's chief medical officer talks about the need of making DNA tests a routine

6 Jul 2017

Genomic testing should become a normal part of NHS care, beginning with cancer patients and those with rare diseases, says the chief medical officer, Dame Sally Davies.In her annual report, Davies...

Department of Health news: A&E gets more funding

6 Jul 2017

The Secretary of State for Health Jeremy Hunt has announced a second wave of funding to ease pressure on hospital emergency departments ahead of next winter.The Secretary of State will confirm that a...

Cancer

A way to stop cancer from metastasizing may have been found

29 Jun 2017 • 4 comments

Metastasis is the main cause of death in cancer, and current treatments against it are ineffective. But new research may have found a way to slow down, and perhaps even halt, the spread of cancer...

Half of adults in Britain walk less than a mile a day

29 Jun 2017

Britons are being urged to take to their feet after research showed more than half of adults walk less than a mile a day.A poll of 2,198 adults conducted by YouGov and commissioned by the charity...

Prostate cancer

Prostate cancer blood test 'helps target treatment'

27 Jun 2017

Scientists have developed a blood test that could pick out which men with advanced prostate cancer would benefit from a new drug treatment. The test detects cancer DNA in the blood, helping doctors...

Arthritis
Rheumatoid arthritis

EU backs second biosimilar copy of Humira, world's top drug

26 Jun 2017

European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the...